Arrowhead Pharmaceuticals, Inc. ARWR
44.21 USD -3.57 (-7.47%)
Regular-session close
44.21 0.00 0.00%
After hours · Nov 16, 4:37 PM ET
44.07 Day range 47.41
37.06 52-week range 95.49
- YTD
- -33.41%
- 1 year
- +7.15%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Sep 30, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Sep 30, 2026 | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 |
|---|---|---|---|---|---|
| 450.82M | 829.45M | 3.55M | 240.74M | 243.23M | |
| 449.02M | 829.45M | 3.55M | 240.74M | 243.23M | |
| -707.17M | 98.35M | -601.08M | -205.00M | -178.51M | |
| -724.21M | -1.63M | -599.49M | -205.28M | -176.06M | |
| -5.11 | -0.01 | -5.00 | -1.92 | -1.67 |
Balance sheet
| Fiscal year | FY 2026 Sep 30, 2026 | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 |
|---|---|---|---|---|---|
| 62.73M | 226.55M | 102.69M | 110.89M | 108.00M | |
| 1.74B | 1.39B | 1.14B | 765.55M | 691.94M | |
| 1.69B | 881.88M | 948.74M | 478.39M | 273.60M | |
| 1.40B | 733.68M | 851.91M | 383.50M | 81.58M | |
| 50.31M | 466.05M | 185.44M | 271.34M | 398.52M |
Cash flow
| Fiscal year | FY 2026 Sep 30, 2026 | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 |
|---|---|---|---|---|---|
| -271.95M | 179.55M | -462.85M | -153.89M | -136.13M | |
| -670.48M | -129.29M | -420.07M | -96.16M | -5.42M | |
| 776.82M | 74.01M | 870.52M | 253.05M | 65.19M | |
| -227.00M | -22.67M | -141.47M | -176.74M | -52.78M | |
| -165.61M | 124.26M | -12.40M | 3.01M | -76.36M |
